SH

Stuart Hughes

Chief Executive Officer

Nuage Therapeutics

Oxford, England


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Nuage Therapeutics
Industry
research
Employees
25.0
Seniority
C suite
Annual Revenue
3222000.0
Total Funding
13110600.0
Latest Funding
Seed

Technologies

Outlook Mobile Friendly WordPress.org IoT

Keywords

biotechnology research small molecule modulators disordered targets chemical biology biomolecular condensation selective drugs protein targeting intrinsically disordered proteins drug discovery high-throughput screening biomedical research gene expression regulation oncology research medicinal chemistry therapeutic indications biotech startup innovative drug development preclinical candidate selection personalized medicine biophysics molecular biology genome structure transcriptional control clinical trials healthcare investment venture capital biopharma sector cross-disciplinary science biotechnology companies scientific collaboration healthcare innovation data analysis mechanistic studies pharmaceutical industry research funding grant support product development biomedical engineering life sciences clinical applications market strategy healthcare solutions protein interaction drug efficacy competition analysis molecular therapeutics industry partnerships scientific leadership health care health wellness & fitness hospital & health care data analytics

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans